LAGUNA HILLS, CA — ITNS, (Marketwired) — 09/27/16 — Itonis, Inc. (OTC PINK: ITNS) is pleased to announce that its Emesyl® anti-nausea homeopathic product is again available for purchase via Amazon.com. Emesyl® is listed for sale in Amazon’s Health, Household & Personal Care category. The product is also being fulfilled by Amazon and can be found for purchase here: https://www.amazon.com/Itonis-Pharmaceuticals-Emesyl-Nausea-Relief/dp/B00U20H3KI/ref=sr_1_1_a_it?ie=UTF8&qid=1474906172&sr=8-1&keywords=emesyl “We’re pleased to be able to offer Emesyl® for sale on Amazon again. This provides Itonis with a greater exposureRead more
- Cannabis Strategic acquires Fitamins CBD brand and distribution network
- PotNetwork Holdings, Inc. Reports 6-Month Revenues of over $12 Million, or More than Two Times its Revenues for the Same Period in 2017
- Precision Therapeutics Reports Second Quarter 2018 Financial Results
- Duos Technologies Reports Record Second Quarter 2018 Results; Increases Full Year 2018 Revenue Guidance to $10.1 Million
- Argentum 47, Inc. is Formally Retained as Corporate Advisor to Creditum Limited, a Disruptive Technology Company Lending Money to Holders of Various Digital Currencies and Offering Other Financial Instruments
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More